Feb 12 2024 |
EnforceMintz — DOJ and OIG Guidance Emphasizes the Importance of a Robust and Dynamic Compliance Program |
Mintz |
Feb 9 2024 |
Gold Dome Report – Legislative Day 18 (2024) |
Nelson Mullins |
Feb 9 2024 |
HHS Publishes New Rights of Conscience Final Rule |
McDermott Will & Schulte LLP |
Feb 9 2024 |
Prohibiting Gender-Affirming Care for Minors: Update on Texas Senate Bill 14-Related Lawsuits |
McDermott Will & Schulte LLP |
Feb 9 2024 |
McDermottPlus Check-Up: February 9, 2024 |
McDermott Will & Schulte LLP |
Feb 9 2024 |
HHS-OCR Finalizes Modifications to Part 2 Rules |
Barnes & Thornburg LLP |
Feb 9 2024 |
EnforceMintz — Government Scrutiny of Medicare Advantage Organizations Expected to Continue in 2024 |
Mintz |
Feb 9 2024 |
Three Individuals Sentenced for $3.5 Million COVID-19 Relief Fraud Scheme |
ArentFox Schiff LLP |
Feb 9 2024 |
Competition Currents | February 2024 |
Greenberg Traurig, LLP |
Feb 9 2024 |
Federal Jury Convicts Six Defendants of Obstructing Access to Reproductive Health Services Facility in Violation of the FACE Act and Other Civil Rights Statutes |
ArentFox Schiff LLP |
Feb 9 2024 |
HHS Finalizes Updates to “Part 2” Regulations to Align Disclosure Rules with HIPAA and Promote More Coordinated Substance Use Disorder Care |
Robinson & Cole LLP |
Feb 9 2024 |
OSH Law Primer, Part II: Creating Standards and Regulations |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Feb 9 2024 |
OSHA Updates Its Process Safety Management of Highly Hazardous Chemicals Instruction |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Feb 9 2024 |
Trending in Telehealth: January 29 – February 5, 2024 |
McDermott Will & Schulte LLP |
Feb 9 2024 |
This Week in 340B: January 31 – February 7, 2024 |
McDermott Will & Schulte LLP |
Feb 8 2024 |
Gold Dome Report – Legislative Day 17 (2024) |
Nelson Mullins |
Feb 8 2024 |
WHO Publishes Guidance for Ethics and Governance of AI for Healthcare Sector |
Robinson & Cole LLP |
Feb 8 2024 |
HHS Addresses the Growing Influence of Artificial Intelligence in Health Care |
Robinson & Cole LLP |
Feb 8 2024 |
EnforceMintz — Despite Few Enforcement Actions in 2023, PE Investment in Health Care Remains a Hot Topic |
Mintz |
Feb 8 2024 |
EnforceMintz — Tele-Fraud Enforcement in 2023 Remained Focused on Same Schemes as Years Past |
Mintz |
Feb 8 2024 |
EnforceMintz — COVID-19 Fraud Enforcement Unlikely to Slow Down in 2024 |
Mintz |
Feb 8 2024 |
CMS Finalizes New Interoperability Rule Promoting Improvements to Prior Authorization Processes |
K&L Gates LLP |
Feb 8 2024 |
The Key Health Care Initiatives Proposed in Governor Hochul’s Fiscal Year (FY) 2025 Executive Budget |
Proskauer Rose LLP |
Feb 8 2024 |
Subcontractors’ COVID-19-Related Claims Survive Motion to Dismiss |
Bradley Arant Boult Cummings LLP |
Feb 7 2024 |
Gold Dome Report – Legislative Day 16 (2024) |
Nelson Mullins |
Feb 7 2024 |
The MHPAEA Proposed Rule: Standards of Care and Medical Necessity |
McDermott Will & Schulte LLP |
Feb 7 2024 |
Opioid Treatment Programs: SAMHSA Makes Permanent Regulatory Flexibilities |
Foley & Lardner LLP |
Feb 7 2024 |
Employment Law This Week Episode 333 - California’s Non-Compete Notice Deadline Approaches, California Workplace Violence Regulations, Estrada Decision Keeps Door Open for PAGA Challenges [Video, Podcast] |
Epstein Becker & Green, P.C. |
Feb 7 2024 |
Navigating Health Care Data Management: Proposed Changes to HIPAA’s Privacy Rule |
Varnum LLP |
Feb 7 2024 |
Buying or Selling a Hospice? The 36-Month Rule Prohibiting Change of Ownership Now Applies |
Greenberg Traurig, LLP |
Feb 6 2024 |
Gold Dome Report – Legislative Day 15 (2024) |
Nelson Mullins |
Feb 6 2024 |
New SAMHSA Rule Expands Access to Medications for the Treatment of Opioid Use Disorder |
Polsinelli PC |
Feb 6 2024 |
The New Texas Law on Vaccination Mandates: What Changes Do Employers Need to Make Now? |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Feb 6 2024 |
What You Need to Know About the New 2024 Medicaid Asset and Income Thresholds |
Norris McLaughlin P.A. |
Feb 6 2024 |
Transparency in Coverage Rules: When Accurate Estimates for Low‑Utilization Items and Services Are Not Available |
Proskauer Rose LLP |